Inventor
JANCARIK ANDREJ
CZ12 patents
Patents
12 patentsUS10954257B2Mar 23, 2021
Prodrugs of glutamine analogs
UNIV JOHNS HOPKINS4 citations83
US10738066B2Aug 11, 2020
Prodrugs of glutamine analogs
UNIV JOHNS HOPKINS5 citations83
US10336778B2Jul 2, 2019
Prodrugs of glutamine analogs
UNIV JOHNS HOPKINS8 citations83
US9988407B2Jun 5, 2018
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
UNIV JOHNS HOPKINS11 citations82
US11325931B2May 10, 2022
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
UNIV JOHNS HOPKINS2 citations71
US11059775B2Jul 13, 2021
Prodrug compositions and utility of hydroxamate-based GCPII inhibitors
UNIV JOHNS HOPKINS2 citations71
US10544176B2Jan 28, 2020
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
UNIV JOHNS HOPKINS2 citations71
US11932664B2Mar 19, 2024
Prodrugs of prostate specific membrane antigen (PSMA) inhibitor
UNIV JOHNS HOPKINS0 citations61
US11926640B2Mar 12, 2024
Prodrugs of glutamine analogs
UNIV JOHNS HOPKINS0 citations61
US11866394B2Jan 9, 2024
Prodrugs of hydroxamate-based GCPII inhibitors
UNIV JOHNS HOPKINS0 citations60
US11759444B2Sep 19, 2023
Methods for cancer and immunotherapy using prodrugs of glutamine analogs
UNIV JOHNS HOPKINS0 citations59
US11712435B2Aug 1, 2023
Mebendazole prodrugs with enhanced solubility and oral bioavailability
UNIV JOHNS HOPKINS0 citations48